piracetam has been researched along with Anterior Horn Cell Disease in 1 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Levetiracetam was well tolerated." | 6.74 | Open-label pilot trial of levetiracetam for cramps and spasticity in patients with motor neuron disease. ( Bedlack, RS; Hawes, J; Heydt, D; Pastula, DM, 2009) |
| "Levetiracetam was well tolerated." | 2.74 | Open-label pilot trial of levetiracetam for cramps and spasticity in patients with motor neuron disease. ( Bedlack, RS; Hawes, J; Heydt, D; Pastula, DM, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bedlack, RS | 1 |
| Pastula, DM | 1 |
| Hawes, J | 1 |
| Heydt, D | 1 |
1 trial available for piracetam and Anterior Horn Cell Disease
| Article | Year |
|---|---|
Open-label pilot trial of levetiracetam for cramps and spasticity in patients with motor neuron disease.
Topics: Adult; Aged; Anticonvulsants; Disease Progression; Humans; Levetiracetam; Middle Aged; Motor Neuron | 2009 |